Norgestimato [INN-Spanish] | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Norgestimato [INN-Spanish]
Canada

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

dmfs-not-supported-m-2025-05-19

Chirogate is a professional Prostaglandin manufacturer.

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Norgestimato [INN-Spanish]

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 10 USDMF, 6 CEP/COS, 4 NDC API, 7 Listed Suppliers, $ API Reference Price

18 API Suppliers
10 USDMF
6 CEP/COS
4 NDC API
7 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

64 FDF Dossiers, 40 FDA Orange Book, 18 Canada, 3 South Africa, 3 Listed Dossiers

64 FDF Dossiers
40 FDA Orange Book
18 Canada
3 South Africa
3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

DIGITAL CONTENT

13 News #PharmaBuzz

13 News #PharmaBuzz

MARKET PLACE

1 APIs

1 APIs

REF. STANDARDS & IMPURITIES

2 EDQM, 3 Others

2 EDQM
3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 12,440 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

18 All

01 12APOTEX INC

02 6GLENMARK PHARMACEUTICALS CANADA INC.

filter Active Ingredients Reset all filters

18 All

01 18NORGESTIMATE

filter Dosage Form Reset all filters

18 All

01 18TABLET

filter Brand Name Reset all filters

18 All

01 3TRI-CIRA 21

02 3TRI-CIRA 28

03 3TRI-CIRA LO 21

04 3TRI-CIRA LO 28

05 3TRI-JORDYNA 21

06 3TRI-JORDYNA 28

List of Suppliers

Product Main Page

01

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 21

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging : 21

Approval Date :

Application Number : 2401967

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 21

Dosage Form : TABLET

Dosage Strength : 0.215MG

Packaging : 21

Approval Date :

Application Number : 2401967

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 21

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging : 21

Approval Date :

Application Number : 2401967

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 28

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging : 28

Approval Date :

Application Number : 2401975

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 28

Dosage Form : TABLET

Dosage Strength : 0.215MG

Packaging : 28

Approval Date :

Application Number : 2401975

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 28

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging : 28

Approval Date :

Application Number : 2401975

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA 21

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging :

Approval Date :

Application Number : 2508087

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA 21

Dosage Form : TABLET

Dosage Strength : 0.215MG

Packaging :

Approval Date :

Application Number : 2508087

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA 21

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging :

Approval Date :

Application Number : 2508087

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA 28

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging :

Approval Date :

Application Number : 2508095

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!